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STUDY QUESTION: Is labour, both at term and preterm, associated with alterations in decidual lymphocyte densities and widespread
changes to the decidual transcriptome?
SUMMARY ANSWER: The onset of parturition, both at term and preterm, is associated with widespread gene expression changes in the
decidua, many of which are related to inﬂammatory signalling, but is not associated with changes in the number of any of the decidual lympho-
cyte populations examined.
WHAT IS KNOWN ALREADY: Given its location, directly at the maternal–foetal interface, the decidua is likely to play a pivotal role in
the onset of parturition, however, the molecular events occurring in the decidua in association with the onset of labour, both at term and pre-
term, remain relatively poorly deﬁned. Using ﬂow cytometry and microarray analysis, the present study aimed to investigate changes to the
immune cell milieu of the decidua in association with the onset of parturition and deﬁne the decidual gene signature associated with term and
preterm labour (PTL).
STUDY DESIGN, SIZE, DURATION: This study used decidual samples collected from 36 women across four clinical groups: term
(38–42 weeks of gestation) not in labour, TNL; term in labour, TL; preterm (<35 weeks of gestation)not in labour, PTNL; and preterm in
labour, PTL.
PARTICIPANTS/MATERIALS, SETTING, METHODS: Decidual lymphocytes were isolated from fresh decidual tissue collected from
women in each of our four patient groups and stained with a panel of antibodies (CD45, CD3, CD19, CD56, CD4, CD8 and TCRVα24-
Jα18) to investigate lymphocyte populations present in the decidua (TNL, n = 8; TL, n = 7; PTNL, n = 5; PTL, n = 5). RNA was extracted
from decidual tissue and subjected to Illumina HT-12v4.0 BeadChip expression microarrays (TNL, n = 11; TL, n = 8; PTNL, n = 7; PTL, n =
10). Quantitative real-time PCR (qRT-PCR) was used to validate the microarray results.
MAIN RESULTS AND THE ROLE OF CHANCE: The relative proportions of decidual lymphocytes (T cells, NK cells, B cells and invari-
ant natural killer (iNKT) cells) were unaffected by either gestation or labour status. However, we found elevated expression of the non-
classical MHC-protein, CD1D, in PTL decidua samples (P < 0.05), suggesting the potential for increased activation of decidual invariant NKT
(iNKT) cells in PTL. Both term and PTL were associated with widespread gene expression changes, particularly related to inﬂammatory sig-
nalling. Up-regulation of candidate genes in TL (IL-6, PTGS2, ATF3, IER3 and TNFAIP3) and PTL (CXCL8, MARCO, LILRA3 and PLAU) were con-
ﬁrmed by qRT-PCR analysis.
LARGE SCALE DATA: Microarray data are available at www.ebi.ac.uk/arrayexpress under accession number E-MTAB-5353.
LIMITATIONS REASONS FOR CAUTION: Whilst no changes in lymphocyte number were observed across our patient samples, we
did not investigate the activation state of any of the immune cell sub-populations examined, therefore, it is possible that the function of these
cells may be altered in association with labour onset. Additionally, the results of our transcriptomic analyses are descriptive and at this stage,
we cannot prove direct causal link with the up-regulation of any of the genes examined and the onset of either term or PTL.
© The Author 2017. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse,
distribution, and reproduction in any medium, provided the original work is properly cited.
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WIDER IMPLICATIONS OF THE FINDINGS: Our ﬁndings demonstrate that the onset of parturition is associated with widespread
changes to the decidual transcriptome, and there are distinct gene expression changes associated with term and PTL. We conﬁrmed that an
inﬂammatory signature is present within the decidua, and we also report the up-regulation of several genes involved in regulating the inﬂam-
matory response. The identiﬁcation of genes involved in regulating the inﬂammatory response may provide novel molecular targets for the
development of new, more effective therapies for the prevention of preterm birth (PTB). Such targets are urgently required.
STUDY FUNDING AND COMPETING INTEREST(S): This work was supported by Medical Research Council (grant number MR/
L002657/1) and Tommy’s, the baby charity. Jane Norman has had research grants from the charity Tommy’s and from the National Institute
for Health Research on PTB during the lifetime of this project. Jane Norman also sits on a data monitoring committee for GSK for a study on
PTB prevention and her institution receives ﬁnancial recompense for this. The other authors do not have any conﬂicts of interest to declare.
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Introduction
Preterm birth (PTB), deﬁned as birth before 37 weeks of gestation,
remains a major public health concern. Rates of PTB have remained
relatively unchanged in recent decades, with data from many countries
actually demonstrating increased PTB rates (Norman et al., 2009;
Blencowe et al., 2012). Globally, PTB is estimated to account for
11.1% of all live births, resulting in ~15 million babies being born pre-
maturely each year (Blencowe et al., 2012). Despite, signiﬁcant med-
ical advances in the care of premature babies, PTB remains the single
biggest cause of neonatal death and the second most common cause
of deaths in children under ﬁve (Blencowe et al., 2013). Current thera-
peutic options to stop preterm labour (PTL) are limited and largely
ineffective (Norman and Shennan, 2013). This is likely due to the fact
that the primary therapy is treatment with a tocolytic agent, but these
drugs only target myometrial contractions, which are a single end-
point in the cascade of events leading to parturition (Haas et al., 2012).
The development of novel, more effective, therapies is hindered by a
lack of understanding of the underlying mechanisms leading to partur-
ition, both physiologically at term, and in pathological PTL.
Studies over recent years have conclusively shown that parturition is
an inﬂammatory event associated with an inﬁltration of immune cells into
the cervix, myometrium and foetal membranes with increased produc-
tion of pro-inﬂammatory mediators in the utero-placental tissues
(Denison et al., 1998; Thomson et al., 1999; Sennstrom et al., 2000;
Young et al., 2002; Osman et al., 2003). These ﬁndings have been sup-
ported by genome-wide analyses of gestational tissues, which have
demonstrated that labour at term is associated with a core inﬂammatory
response (Hassan et al., 2006; Bollapragada et al., 2009; Mittal et al.,
2010; Stephen et al., 2015; Sharp et al., 2016). PTL is thought to occur
via the premature activation of similar inﬂammatory events, but import-
antly the underlying mechanism activating these inﬂammatory cascades
are likely to differ between term and PTL, with PTL thought to occur in
response to pathological processes, such as intrauterine infection, decid-
ual haemorrhage or stress (Rinaldi et al., 2011; Romero et al., 2014).
The majority of research has focussed on deﬁning the molecular
events underlying myometrial contractions, foetal membrane rupture
and cervical ripening, with less focus being given to the role of the
decidua in the onset of labour. Given that the uterine decidua is located
directly at the maternal–foetal interface, it is ideally placed to have a key
role in the events leading to parturition. During pregnancy, the decidua
can be subdivided depending on the point of contact with foetal tissues.
The decidua basalis, describes the decidual tissue which surrounds the
placenta and invading interstitial trophoblasts, while the decidua parieta-
lis, describes the decidual tissue which is in contact with the foetal mem-
branes, speciﬁcally the chorion layer (Cunningham et al., 2014).
Studies examining the changes in decidual immune cell populations
with the onset of labour have provided conﬂicting results, with one
study reporting no changes in leucocyte population (Osman et al.,
2003), while others have reported increases in NK cells, T cells and
macrophages, in term labour (Sindram-Trujillo et al., 2004; Hamilton
et al., 2012; Gomez-Lopez et al., 2013). The decidual leucocyte
changes occurring in PTL have been less well examined, but elevated
macrophage, neutrophil, T cell and NK cell numbers in the decidua
have been reported in women with PTL (Hamilton et al., 2012).
Rodent studies have demonstrated that this decidual leucocyte inﬁltra-
tion precedes the onset of parturition (Hamilton et al., 2012; Shynlova
et al., 2013b; Rinaldi et al., 2014), suggesting that alterations in the
decidual immune cell populations may be an important early event in
the inﬂammatory events surrounding labour.
There has been a long-standing interest in deﬁning the role of the
decidua in the onset of parturition, with ‘decidual activation’ being pro-
posed as critical to labour in the 1980s (Casey and MacDonald, 1988).
Elevated prostaglandin output and the production of pro-inﬂammatory
mediators, such as cytokines and matrix metalloproteinases (MMPs),
from the decidua is thought to stimulate myometrial contractions and
extracellular matrix (ECM) remodelling in the foetal membranes and
cervix, thus stimulating the progression of labour (Makino et al., 2007;
Snegovskikh et al., 2011). A recent review by Norwitz et al. (2015), pro-
poses that the decidua is key to triggering the cascade of events, which
result in the onset of labour. During pregnancy, the decidua is integral to
maintaining uterine quiescence; with advancing gestational age, there is
withdrawal of active suppression and/or the enhanced ability of the
decidua to induce inﬂammatory signals, which results in the initiation of
the pro-inﬂammatory signalling cascade, culminating in parturition. In
this theory, PTB is proposed to occur as a result of premature dysregu-
lation of decidual inﬂammation, which could be induced by the patho-
logic processes already mentioned (Norwitz et al., 2015).
Hence, it is clear that improving our understanding of the molecular
mechanisms taking place in the decidua during labour, both at term
and preterm, is critical to the development of novel therapies to delay
PTL and reduce the incidence of PTB. In this study we aimed to investi-
gate changes in the decidual lymphocyte populations in relation to
labour onset, both at term and preterm, and to use microarray analysis
to determine the decidual gene signature associated with term and
preterm parturition. We hypothesized that the onset of labour, both
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at term and preterm, will be associated with changes to the decidual
lymphocyte populations, that labour will result in widespread changes
to the decidual transcriptome relating to inﬂammatory gene signalling
and these changes may differ in the context of physiological term
labour and pathological PTL.
Materials andMethods
Sample collection
Decidual tissue was isolated from foetal membrane samples collected
from women who delivered at Edinburgh Royal Inﬁrmary, with written and
informed consent, according to the ethical approval and governance
granted to the Edinburgh Reproductive Tissues BioBank by the West of
Scotland Research Ethics Committee 4 (REC reference: 09/S0704/3) until
30/09/2014; and consequently by the East of Scotland Research Ethics
Service Tayside Committee on Medical Research Ethics B (REC reference:
13/ES/0126).
Samples were collected from women delivering at term (38–42 weeks
of gestation) and preterm (<35 weeks of gestation). A total of 36 women
were recruited from four patient groups: term not in labour (TNL; n =
11), term in labour (TL; n = 8), preterm not in labour (PTNL; n = 7) and
preterm in labour (n = 10). TNL and PTNL samples were collected from
women following caesarean section delivery; TL and PTL samples were
collected following either vaginal delivery or emergency caesarean section
delivery. Patient characteristics are detailed in Table I.
Following delivery, full-thickness foetal membranes were cut from the
placenta and placed in PBS. Samples were either stored at 4°C for no
more than 1–5 h before processing, or processed immediately following
collection. Amnion was removed from the foetal membranes and decidua
parietalis tissue was carefully scraped from the chorion. Samples of decid-
ual tissue were either frozen at −80°C for further RNA and protein ana-
lysis or digested for isolation of decidual lymphocytes.
Isolation of decidual lymphocyte populations
Decidual tissue was ﬁnely minced with scissors and digested overnight at
room temperature with agitation in 20ml of RPMI 1640 (Gibco, Life
Technologies Ltd, Paisley, UK) containing 20% FCS (Gibco), 0.125mg/ml col-
lagenase type IV (Sigma-Aldrich, Poole, UK) and 0.1mg/ml DNase I (Sigma).
The digested tissue was then sequentially ﬁltered through 70 μm and 40 μm
cell strainers (BD Biosciences, Oxford, UK) to obtain a single cell suspension
and centrifuged at 800 g for 5min. The cell pellet was resuspended in 3ml
PBS (Gibco) + 2% FCS and the decidual lymphocytes were isolated by density
gradient centrifugation using Histopaque 1077 (Sigma). The isolated immune
cells were washed in 20ml PBS centrifuged at 800 g for 15min and resus-
pended in 1ml PBS for cell counting and ﬂow cytometry analysis.
Flow cytometry
Flow cytometry was used to investigate the decidual lymphocyte populations
present in term and preterm in labour and non-labouring samples. Due to
the small amount of foetal membrane tissue isolated from preterm patients,
it was not always possible to isolate a large enough population of decidual
mononuclear cells for ﬂow cytometry analysis. Therefore sample sizes for
the ﬂow cytometry analysis were: TNL (n = 8), TL (n = 7), PTNL (n = 5)
and PTL (n = 5). Isolated lymphocytes were incubated with the following
panel of antibodies for 30min on ice: CD45-FITC (1:5, BioLegend,
Cambridge, UK), CD3-PerCP/Cy5.5 (1:100, BioLegend), TCRVα24-Jα18-
PE (1:50; BioLegend), CD56-BV421 (1:100; BioLegend), CD4-BV570 (1:20;
BioLegend), CD8-APC/Cy7 (1:50; BioLegend) and CD19-PE/Cy7 (1:50;
BioLegend). Following this, samples were centrifuged for 5 min at 350 g, the
supernatant was removed and the samples resuspended in 200 μl PBS + 1%
FCS for ﬂow cytometric analysis. The nuclear stain DAPI was added to the
samples as a live/dead marker. Analysis was carried out using the BD LSR
Fortessa and data were collected using BD FACSDiva software and analyised
using FlowJo software (Treestar, Ashland, OR, USA).
RNA extraction and sample preparation
Total RNA was extracted from decidua samples using TRI Reagent and
RNeasy mini kit (Qiagen, Crawley, UK) as per the manufacturer’s
guidelines. The quantity and quality of RNA was assessed using a Nano-
Drop ND 1000 spectrophotometer (Thermo Scientiﬁc, UK). In prepar-
ation for the microarray experiment, 750ng total RNA was ampliﬁed and
biotin-labelled using the Illumina TotalPrep RNA Ampliﬁcation Kit
(Ambion, UK). The quantity and quality of the biotin-labelled cRNA sam-
ples was further assessed by the Wellcome Trust Clinical Research Facility,
Edinburgh using a Bioanalyzer 2100, according to their protocols (Agilent
Technologies LDA UK Limited, Cheshire, UK).
Illumina HT-12v4.0 beadchip expression
microarray
Samples were randomly split over three Illumina HT-12 v4.0 BeadChips to
minimize the effects of inter-chip variability. The chips were imaged using a
BeadArray Reader and raw data were obtained with Illumina BeadStudio
software. Raw data are available at www.ebi.ac.uk/arrayexpress under
accession number E-MTAB-5353.
Microarray analysis
Microarray data analysis was performed by Fios Genomics Ltd
(Bioquarter, Edinburgh, UK). The analysis included quality control and
exploratory analysis of the data sets followed by identiﬁcation of differen-
tially expressed genes (DEGs) and also functional analysis for enrichment
of KEGG pathways amongst the DEGs.
Raw data underwent quality control analysis using the arrayQualityMetrics
package in Bioconductor (Kauffmann and Huber, 2010) to identify outliers.
Two samples (both from PTL group) failed the quality control checks and
were removed from further statistical analysis of the microarray data. The
arrayQualityMetrics analysis scored the samples on the basis of four metrics
(maplot, boxplot, heatmap and manual inspection). Boxplots of the raw,
transformed and normalized data were also assessed manually, as were out-
lier and sample relation plots were generated for all stages of the processing.
One PTL sample failed the automatic quality checks based on two metrics
(Boxplot and Heatmap) and was removed from downstream analyses. The
second PTL sample passed the automatic quality checks as it only failed one
metric (Heatmap). However after manual inspection it clearly appeared to be
an outlier (PCA plot, dendrogram and boxplot) and was therefore removed
from downstream analyses. Data were normalized using robust spline nor-
malization after being subjected to a variance stabilizing transformation.
Network graph analysis
To further analyse the microarray expression data and examine whether
samples within the four patient groups had similar expression proﬁles, we
created a sample–sample network graph in BioLayout Express3D, as
described (Theocharidis et al., 2009; Sharp et al., 2016). The normalized
expression data for the top up-and down-regulated genes (P < 0.05, fold
change ≥1.2) were used for this analysis. In the sample–sample network
graph, each ‘node’ represents a sample which is connected to other sam-
ples by ‘edges’ weighted according to the strength of the sample–sample
Pearson’s correlation coefﬁcient. All correlation values above 0.85 were
used to draw a graph of this similarity matrix. In this network graph, if sam-
ples have similar gene expression signatures they appear closer to each
other in the graph, thus creating a local structure. The Markov Clustering
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algorithm (MCL) (Enright et al., 2002) was performed with the inﬂation
value (MCLi) set at 20.0 to give an unbiased assessment of how the sam-
ples cluster. This can then be further examined by colouring the nodes
according to gestation and labour status to assess whether different patient
groups have similar gene expression proﬁles.
Quantitative real-time PCR
To validate the results of the microarray experiment, total RNA (300ng) was
reverse transcribed using the High Capacity cDNA Reverse Transcription kit
(Applied Biosystems). QRT-PCR was carried out to quantify the mRNA
expression of speciﬁc genes of interest. Details of the pre-designed gene
expression assays from Applied Biosystems used are given in Supplementary
Table I. Target gene expression was normalized for RNA loading using ACTB
and the expression in each sample was calculated relative to the mean of the
TNL samples, using the 2−ΔΔCt method of analysis. All qRT-PCR analysis
was performed on an Applied Biosystems 7900HT instrument.
Western blotting
Total decidual protein was extracted in RIPA buffer (Sigma) supplemented with
cOmplete™ Protease Inhibitor Cocktail tablet (Sigma). Brieﬂy, 20 μg of
extracted protein was separated on NuPAGE 4–12% Bis-Tris precast gels
(Invitrogen, Life Technologies Ltd, Paisley, UK) and transferred to Immobilon-FL
polyvinylidene diﬂuoridemembrane (Millipore, Hertfordshire, UK).
Membranes were blocked in 5% Milk/TBS/0.001% Tween-20 for 1 h at
room temperature and incubated overnight with at 4°C with the primary
antibodies: mouse anti-CD1d (1:250; MAB6979, R&D Systems, Abingdon,
UK) and rabbit anti-β-actin (1:2500; ab8227, Abcam, Cambridge, UK). To
detect the bound proteins, the membrane was incubated with two
ﬂuorescently-labelled secondary antibodies, IRDye 800CW and IRDye
680RD (1:10 000; Li-Cor Biosciences, Nebraska, USA), to detect both the
protein of interest and the β-actin loading control protein simultaneously.
Bands were visualized using a Li-Cor Odyssey Infrared Imaging System and
analysed using Image Studio Software (Li-Cor Biosciences). The intensity of
CD1d ﬂuorescence was calculated relative to β-actin.
Statistics
Data are presented as mean ± SEM. Data were analysed for normal distri-
bution using the Shapiro–Wilk normality test. The speciﬁc statistical ana-
lysis tests performed for the different data sets are detailed in the ﬁgure
legends. Statistical analyses for the decidual immune cell populations, qRT-
PCR and western blotting were performed using GraphPad Prism 6.0 soft-
ware (GraphPad, San Diego, CA, USA). P < 0.05 was considered statistic-
ally signiﬁcant.
Results
Decidual lymphocyte sub-populations in term
and preterm labouring and non-labouring
samples were not signiﬁcantly different
Flow cytometry analysis was carried out to characterize the decidual
lymphocyte populations present both at term and preterm, in labour-
ing and non-labouring samples. The gating strategy used is summarized
.............................................................................................................................................................................................
Table I Demographic and clinical characteristics of the study groupsa.
TNL (n = 11) TL (n= 8) PTNL (n= 7) PTL (n = 10)
Maternal age (year) 34 (30–43) 26 (22–40) 34 (18–39) 30 (16–39)
Parityb 1 (0–2) 0 (0–1) 0 (0–2) 0 (0–3)
BMI (kg/m2)c 22.7 (19.9–28.1) 27.1 (21.0–28.7) 24.4 (22.1–26.2) 24.8 (19.5–30.0)
Gestation at delivery (week) 39.3 (39.0–41.0) 40.1 (38.2–41.1) 32.4 (29.0–34.4)*## 30.4 (24.0–34.6)**####
Indication for caesarean section (n)
Foetal distress 0 2 0 3
Failure to progress 0 3 0 0
Breech presentation 2 0 0 2
Obstetric history 6 0 0 0
IUGR 0 0 4 0
Pre-eclampsia 0 0 2 0
Other or missing 3 3 1 5
Foetal membrane rupture
Spontaneous 0 5 0 2
Artiﬁcial 0 3 0 2
PPROM 0 0 0 6
None or missing 11 0 7 0
Evidence of chorioamnionitis: n (%)d 0 (0%) 5 (50%)
Evidence of placental abruption: n (%)e 0 (0%) 1 (10%)
aThe numbers are median and range unless otherwise indicated.
bParity data were missing from one patient in the PTL group.
cBMI at booking to antenatal care. Due to patient transfer, BMI was not available for three PTNL patients and three PTL patients.
dChorioamnionitis status from available pathology reports for preterm patients. Pathology reports were not available for two PTL patients.
ePlacental abruption conﬁrmed from available pathology reports from preterm patients. Pathology reports were not available for two PTL patients.
*P < 0.05, **P < 0.01 versus TNL; ##P < 0.01, ####P < 0.0001 versus TL; Kruskal–Wallis with post hoc Dunn test.
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in Fig. 1A. The percentage of decidual CD45+ cells (expressed as a
proportion of all decidual lymphocytes) was found to be similar at
both term and preterm and in labouring and non-labouring samples
(Fig. 1B). The majority of CD45+ lymphocytes were made up of NK
cells (Fig. 1C) and T cells (Fig. 1E), with B cells (Fig. 1D) accounting for
a much smaller proportion of the decidual CD45+ lymphocyte popula-
tion. The analysis did not reveal any statistically signiﬁcant differences
in the proportion of any of these immune cell subsets when comparing
TNL, TL, PTNL and PTL groups. Further analysis of the CD3+ T cells
revealed that both CD4+ (Fig. 1F) and CD8+ (Fig. 1G) T cells are pre-
sent within the decidua, and we did not ﬁnd any effect of gestation or
labour status on the proportion of these cell types.
Decidual iNKT cells did not differ in term and
PTL but their activation status may change
Given the recent studies suggesting that decidual invariant natural killer
(iNKT) cells may play a pathological role in the onset of PTL (Li et al.,
2012, 2015; St Louis et al., 2016), we also examined whether these
cells were present in our samples. We found a very small population
of CD3+ TCRVα24-Jα18+present in our decidual samples (TNL:
0.09% ± 0.02, TL: 0.08% ± 0.02, PTNL: 0.16% ± 0.07, PTL: 0.09 ±
0.04 of decidual CD3+ cell population; Fig. 2A), but as with the other
immune cell subsets examined, we did not ﬁnd a statistically signiﬁcant
difference in the number of iNKT cells when we compared TNL, TL,
PTNL and PTL samples (Fig. 2B). However, we did ﬁnd that the
expression CD1D, which encodes for the non-classical MHC-protein
CD1d and is involved in iNKT cell activation, is signiﬁcantly elevated in
decidual samples collected from PTL women, compared to both
PTNL and TNL (2.3-fold and 1.6-fold greater, respectively; P < 0.05;
PTL mean relative expression, 1.82 ± 0.33; TNL mean relative expres-
sion, 1.15 ± 0.20; PTNL mean relative expression, 0.78 ± 0.11;
Fig. 2C). Decidual PTL samples also had signiﬁcantly elevated CD1d
protein levels compared with TNL samples (2.8-fold greater; P < 0.05;
PTL mean relative expression: 1.78 ± 0.58; TNL mean relative expres-
sion: 0.64 ± 0.09; Fig. 2D).
Microarray analysis of the decidual
transcriptome in term and preterm samples
revealed distinct but overlapping gene
signatures
To explore the gene signatures activated in the decidua during labour,
both physiologically at term and pathologically in PTL, we performed
whole genome microarray analyses on decidual samples collected
from women in each of our four patient groups, TNL, TL, PTNL and
PTL. DEGs were identiﬁed as those with a fold change of ≥1.2 and P <
0.01. Comparisons between the different patient groups identiﬁed 104
DEGs between TL and TNL samples (56 up- and 48 down-regulated
in TL); 112 DEGs between TL and PTL samples (32 up- and 80-down-
regulated in PTL); and 129 DEGs between PTL and PTNL samples (96
up- and 33-down-regulated in PTL). The top 10 DEGs in each com-
parison (TL vs TNL; TL vs PTL and PTL vs PTNL) are shown in
Table II. The full list of DEGs for each comparison is shown in
Supplementary Table II.
To determine whether there was any sample–sample correlation in
the gene signatures identiﬁed by the microarray, we also used a
network graph approach to analyse the microarray data. The sample–
sample network graph was generated using the normalized expression
data for the top up- and down-regulated genes (P < 0.05, fold change
≥ 1.2). Using MCL clustering (MCLi = 20), three separate clusters
were identiﬁed (Fig. 3A). To determine whether there was any rela-
tionship between the expression data and gestation and/or labour sta-
tus, the nodes were coloured according to patient group (Fig. 3B).
This analysis revealed that samples from each patient group had quite
diverse gene expression signatures, as not all samples from any patient
group belonged to a single cluster. However, cluster one is predomin-
antly made up of labouring samples (10 out of the 14 samples in cluster
one come from labouring groups, with six of these samples belonging
to the PTL group and four belonging to the TL group), suggesting that
there are similarities in gene expression in the labouring samples.
Conversely, cluster two is predominantly made up of nodes belonging
to TNL patients (7 out of 11 TNL samples; 2 out of 8 TL samples; 2
out of 8 PTL samples; and 1 out of 7 PTNL samples). Cluster three
contains the remaining samples (3 out of 11 TNL samples; 2 out of 8
TL samples; and 3 out of 7 PTNL samples). Therefore, this network
graph approach reveals that there is quite high variation in decidual
gene expression within the four patient groups. Importantly, however,
75% of PTL samples are contained within cluster 1, suggesting that
there may be a distinct decidual gene expression signature associated
with PTL.
Decidual gene signature associated
with term labour
To further investigate the gene signature of the decidua during physio-
logical labour at term, the signiﬁcantly DEGs in the TL versus TNL
comparison were assessed for KEGG pathway enrichment. This ana-
lysis identiﬁed several enriched KEGG pathways in up-regulated fea-
tures and one enriched KEGG pathway in down-regulated features at
P < 0.05 in TL decidua, compared with TNL decidua (Supplementary
Table III). The signiﬁcantly enriched KEGG pathways in TL samples
included a number of pathways involved in inﬂammation and immunity
(e.g. ‘TNF-signalling pathway’, ‘NOD-like receptor signalling’ and ‘NF-
kappa B signalling’).
We identiﬁed a number of genes of interest that were found to be
signiﬁcantly up-regulated in TL versus TNL samples in the microarray
and examined whether the microarray results could be validated by
qRT-PCR. Our qRT-PCR analysis conﬁrmed that several important
genes involved in inﬂammatory signalling are signiﬁcantly elevated in
decidual TL samples, compared with TNL samples. Speciﬁcally, we
found that IL-6 expression was 10.9-fold higher in TL samples com-
pared to TNL (P < 0.05; TL mean relative expression: 29.54 ± 22.28;
TNL mean relative expression: 2.72 ± 0.65; Fig. 4A); expression of
PTGS2 was 3.5-fold higher in TL decidua versus TNL decidua (P <
0.05; TL mean relative expression: 4.86 ± 1.30; TNL mean relative
expression 1.41 ± 0.43; Fig. 4B); and IER3 mRNA levels were also 5-
fold higher in TL samples, compared with TNL samples (P < 0.05; TL
mean relative expression: 9.38 ± 5.12; TNL mean relative expression:
1.87 ± 0.23; Fig. 4C). Although the expression of each of these three
genes was also found to be elevated in PTL samples, this increase did
not reach statistical signiﬁcance. Interestingly, the expression of the
other two genes we examined were only elevated in TL: decidual
TNFAIP3 expression was 3-fold higher in TL samples, compared with
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Figure 1 Decidual immune cell population analysis in term and PTL. Flow cytometric analysis of isolated decidual mononuclear cells from four
patient groups: TNL (n = 8), TL (n = 7), PTNL (n = 5) and PTL (n = 5). Cells were stained with antibodies raised against the following antigens: CD45,
CD3, CD56, CD19, CD4 and CD8. (A) Gating strategy. Lymphocytes were gated based on their forward light scatter (FSC) and side light scatter
(SSC), doublet cells were removed and live cells were selected based on exclusion of DAPI. Individual cell populations were then identiﬁed based on
antibody staining. (B) Proportion of CD45+ lymphocytes out of all live cells within lymphocyte gate. (C) Proportion of CD3−CD56+ NK cells within
the CD45+ lymphocyte gate. (D) Proportion of CD19+ B cells within the CD45+ lymphocyte gate. (E) Proportion of CD3+ T cells within the CD45+
lymphocyte gate. (F) Proportion of CD4+ T cells within the CD3+ T cell gate. (G) Proportion of CD8+ T cells within the CD3+ T cell gate. Data pre-
sented as mean ± SEM. Data were analysed by Kruskal–Wallis but no signiﬁcant differences were found. PTL, preterm labour.
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TNL (P < 0.001; TL mean relative expression: 5.06 ± 0.94; TNL mean
relative expression: 1.69 ± 0.20; Fig. 4D); and ATF3 expression was
2.8-fold higher in TL samples, compared with TNL (P < 0.05; TL mean
relative expression: 6.54 ± 1.65; TNL mean relative expression:
2.33 ± 0.58; Fig. 4E).
Decidual gene signature associated with PTL
To examine whether we could identify a speciﬁc gene signature asso-
ciated with PTL in the decidua, the signiﬁcantly up- and down-
regulated genes identiﬁed by the microarray were also assessed for
KEGG pathway enrichment. This analysis was carried out for two sep-
arate comparisons, PTL versus TL and PTL versus PTNL, to identify
any speciﬁc differences in the labour process between preterm and
term labour and to identify gene expression differences between the
two pathological conditions of PTL and PTNL. When comparing PTL
and TL decidual samples, KEGG pathway analysis identiﬁed ﬁve
enriched pathways in up-regulated features, and three enriched path-
ways in down-regulated features at P < 0.05 (Supplementary
Table IV). In this comparison, the top up-regulated pathway in PTL
decidua was found to be ‘complement and coagulation cascades’,
while ‘mRNA surveillance’ was the top down-regulated pathway.
When examining PTL versus PTNL samples, the KEGG pathway
enrichment analysis identiﬁed eight enriched pathways in up-regulated
features, and twelve enriched pathways in down-regulated features at
P < 0.05 (Supplementary Table V). Similar to the previous comparison,
‘complement and coagulation cascades’ was one of the top up-
regulated pathways in decidua from PTL samples, along with ‘cyto-
kine–cytokine receptor interaction’.
To further investigate the genetic signature of the decidua during
PTL, we identiﬁed several genes of interest that were suggested to be
important in PTL from both the DEG lists generated from the micro-
array data and also from the KEGG pathway enrichment analysis, and
aimed to validate these genes by qRT-PCR analysis. In accordance
with the microarray results, we found that expression of CXCL8 was
13-fold greater in decidua samples collected from women in PTL,
compared to PTNL samples (P < 0.01; PTL mean relative expression:
30.5 ± 14.8; PTNL mean relative expression: 2.37 ± 0.96; Fig. 5A).
Similarly, decidual expression of MARCO and LILRA3 was also signiﬁ-
cantly elevated in PTL samples (MARCO: 8.1-fold, P < 0.05 vs TL; PTL
mean relative expression: 16.1 ± 5.7; TL mean relative expression:
1.98 ± 0.62; Fig. 5B; LILRA3: 11-fold, P < 0.05 vs TL; 21.8-fold,
Figure 2 Decidual iNKT cells and CD1d in term and PTL. The presence of a decidual iNKT cell population was examined using ﬂow cytometry in
samples from our four patient groups: TNL (n = 8), TL (n = 7), PTNL (n = 5) and PTL (n = 5). (A) Decidual iNKT cells were gated based on their
expression of CD3 and TCRVα24 Jα18. (B) Proportion of iNKT cells within the CD3+ gate. Decidual expression of CD1d was examined at the mRNA
and protein level by qRT-PCR and western blotting, respectively. (C) Decidual CD1D mRNA expression [TNL (n = 11); TL (n = 8), PTNL (n = 7), PTL
(n = 10)]. (D) Decidual CD1d protein expression (n = 7 in each group). Data presented as mean ± SEM. QRT-PCR data analysed by one-way
ANOVA followed by Newman–Keuls post hoc test; ﬂow cytometry and western blot data analysed by Kruskal–Wallis followed by Dunn post hoc test.
*P < 0.05. iNKT, invariant natural killer.
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Table II Top 10 DEGs.
Comparison Symbol Description Fold change P-value
TL vs TNL TNFAIP3 tumour necrosis factor, alpha-induced protein 3 2.716 1.40E–04
IER3 immediate early response 3 2.68 2.37E–03
IL-6 interleukin 6 2.657 8.79E–03
PTGS2 prostaglandin-endoperoxide synthase 2 2.474 2.15E–03
ATF3 activating transcription factor 3 2.31 6.30E–03
PHLDA1 pleckstrin homology-like domain, family A, member 1 2.147 3.98E–03
DUSP5 dual speciﬁcity phosphatase 5 2.066 3.64E–03
NFKBIA nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha 1.988 8.04E–04
ZC3H12A zinc ﬁnger CCCH-type containing 12 A 1.905 3.84E–03
DDIT4 DNA-damage-inducible transcript 4 1.824 4.79E–03
MMP7 matrix metallopeptidase 7 (matrilysin, uterine) −2.387 1.84E–03
ZC3HAV1 zinc ﬁnger CCCH-type, antiviral 1 −1.564 1.51E–05
COL6A3 collagen, type VI, alpha 3 −1.538 4.49E–03
CIRBP cold inducible RNA binding protein −1.456 1.88E–03
NID1 nidogen 1 −1.396 7.91E–03
CYB561D1 cytochrome b561 family, member D1 −1.394 2.64E–03
CLSTN1 calsyntenin 1 −1.355 9.51E–03
LHPP phospholysine phosphohistidine inorganic pyrophosphate phosphatase −1.338 2.94E–03
RAB22A RAB22A, member RAS oncogene family −1.327 9.02E–04
CCDC106 coiled-coil domain containing 106 −1.303 6.30E–03
TL vs PTL FOSB FBJ murine osteosarcoma viral oncogene homologue B 2.538 9.45E–03
FST follistatin 2.325 3.96E–03
HES4 hes family bHLH transcription factor 4 1.691 9.09E–04
KLF4 Kruppel-like factor 4 (gut) 1.563 9.62E–03
SASH1 SAM and SH3 domain containing 1 1.493 8.10E–03
HRK harakiri, BCL2 interacting protein 1.492 9.84E–03
NEDD9 neural precursor cell expressed, developmentally down-regulated 9 1.489 5.24E–03
ELMSAN1 ELM2 and Myb/SANT-like domain containing 1 1.44 2.50E–03
FOXC1 forkhead box C1 1.418 4.11E–03
CCNB1IP1 cyclin B1 interacting protein 1, E3 ubiquitin protein ligase 1.414 6.07E–03
FGA ﬁbrinogen alpha chain −4.108 6.28E–03
FGG ﬁbrinogen gamma chain −3.688 5.88E–04
FGB ﬁbrinogen beta chain −2.753 2.53E–03
PLAT plasminogen activator, tissue −2.235 5.73E–03
MARCO macrophage receptor with collagenous structure −2.087 4.03E–03
LILRA3 leucocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3 −1.945 9.45E–03
NR1H3 nuclear receptor subfamily 1, group H, member 3 −1.769 8.67E–03
KCNK4 potassium channel, subfamily K, member 4 −1.75 1.95E–03
TNFRSF8 tumour necrosis factor receptor superfamily, member 8 −1.72 1.53E–03
WARS tryptophanyl-tRNA synthetase −1.712 9.12E–03
PTL vs PTNL CXCL8 chemokine (C-X-C motif) ligand 8 5.441 2.49E–03
CEMIP cell migration inducing protein, hyaluronan binding 3.338 6.97E–03
S100A8 S100 calcium binding protein A8 3.193 1.02E–03
FGG ﬁbrinogen gamma chain 3.023 3.76E–03
SOD2 superoxide dismutase 2, mitochondrial 2.89 2.04E–03
FGB ﬁbrinogen beta chain 2.784 3.08E–03
NAMPT nicotinamide phosphoribosyltransferase 2.742 1.03E–03
Continued
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P < 0.01 vs PTNL; PTL mean relative expression: 65.89 ± 31.65; TL
mean relative expression: 5.95 ± 1.69; PTNL mean relative expression:
3.02 ± 0.85; Fig. 5C).
Given that the microarray analysis identiﬁed FGA, FGB and FGG to
be among the top up-regulated genes in PTL decidual samples, and
that KEGG pathway enrichment analysis identiﬁed ‘complement and
coagulation cascades’ to be a signiﬁcantly enriched pathway in PTL, we
also examined the expression of several key genes involved in coagula-
tion by qRT-PCR. We found that although the mean concentrations of
FGA (PTL mean relative expression: 30.38 ± 16.14; TL mean relative
expression: 2.23 ± 1.05; Fig. 5D), FGB (PTL mean relative expression:
10.98 ± 4.51; TL mean relative expression: 2.03 ± 0.54; Fig. 5E) and
FGG mRNAs (PTL mean relative expression: 7.85 ± 3.39; TL mean
relative expression: 1.17 ± 0.29; Fig. 5F) were all elevated in PTL
decidua samples, but this increase did not reach statistical signiﬁcance
(13.6-fold, 5.4-fold; and 6.7-fold increased expression vs TL samples,
P = 0.21, P = 0.36 and P = 0.06, respectively) due to variations
between samples (e.g. Fig. 5D). Similarly, the signiﬁcantly elevated
expression of tissue plasminogen activator, PLAT, observed in the
microarray analysis was not validated by qRT-PCR (2.3-fold increase
.............................................................................................................................................................................................
Table II Continued
Comparison Symbol Description Fold change P-value
FGG ﬁbrinogen gamma chain 2.687 9.45E–04
S100A9 S100 calcium binding protein A9 2.547 9.93E–04
AQP9 aquaporin 9 2.528 3.60E–03
FOSB FBJ murine osteosarcoma viral oncogene homologue B −2.652 8.73E–03
TACSTD2 tumour-associated calcium signal transducer 2 −2.334 9.47E–03
MGAT3 mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase −1.702 2.04E–03
SASH1 SAM and SH3 domain containing 1 −1.536 6.36E–03
CYB561D1 cytochrome b561 family, member D1 −1.467 1.96E–03
FAM53B family with sequence similarity 53, member B −1.448 5.53E–03
CRYZ crystallin, zeta (quinone reductase) −1.438 9.11E–03
C22orf29 chromosome 22 open reading frame 29 −1.436 2.44E–03
ZHX3 zinc ﬁngers and homeoboxes 3 −1.428 2.39E–04
VTCN1 V-set domain containing T cell activation inhibitor 1 −1.412 1.12E–03
DEG, differentially expressed gene.
Figure 3 Sample–sample network graph of microarray data. Normalized expression data for the top up-and down-regulated genes (P < 0.05, fold
change ≥ 1.2) identiﬁed by microarray analysis were visualized using BioLayout Express3D. Each node represents a different patient sample and edges
are coloured to reﬂect the Pearson correlation that they represent. Red edges indicate high correlation, and blue edges represent low correlation. The
same data set is used for each graph. (A) unbiased MCL cluster (MCLi = 20). (B) Nodes are coloured by gestation and labour status into our four sam-
ple groups: TNL (n = 11), TL (n = 9), PTNL (n = 7) and PTL (n = 8).
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PTL vs. TL, P = 0.19; PTL mean relative expression: 3.98 ± 0.69; TL
mean relative expression: 1.75 ± 0.40; Fig. 5G). However, expression
of the urokinase-type plasminogen activator, PLAU, was signiﬁcantly
greater in PTL decidua samples, compared with TL samples (2-fold,
P < 0.05; PTL mean relative expression: 2.34 ± 0.34; TL mean relative
expression: 1.16 ± 0.33; Fig. 5H).
Discussion
The decidua, situated directly at the maternal–foetal interface, is
ideally located to play a pivotal role in the onset of parturition, both at
term and preterm. However, compared to other gestational tissues
(myometrium, foetal membranes and cervix), the exact role the
decidua plays in the onset of labour remains relatively poorly under-
stood. In this study, we describe the lymphocyte milieu of the human
decidua and examine for the ﬁrst time the decidual transcriptome in
both normal physiological labour at term and in pathological PTL. We
found no changes in any of the immune cell populations studied (NK
cells, B cells, T cells and iNKT cells) in association with parturition, but
an up-regulation in inﬂammatory gene expression in association with
term and preterm parturition and of the iNKT cell activation marker
CD1D in association with PTL.
Figure 4 QRT-PCR validations of gene expression changes in TL decidua samples. Decidual expression of selected genes identiﬁed as signiﬁcantly
elevated in TL in the microarray analysis was examined across our four sample groups by qRT-PCR [TNL (n = 11), TL (n = 9), PTNL (n = 7) and PTL
(n = 10)]. (A) IL-6 expression, (B) PTGS2 expression, (C) IER3 expression, (D) TNFAIP3 expression and (E) ATF3 expression. Data are presented as
mean fold change ± SEM. Data were analysed by one-way ANOVA followed by Tukey post hoc test. *P < 0.05, ***P < 0.001.
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Figure 5 QRT-PCR validations of gene expression changes in PTL decidua samples. Decidual gene expression of selected genes identiﬁed as signiﬁ-
cantly elevated in PTL samples in the microarray analysis was examined across our four sample groups by qRT-PCR [TNL (n = 11), TL (n = 9), PTNL
(n = 7), PTL (n = 10)]. (A) CXCL8 expression, (B) MARCO expression, (C) LILRA3 expression, (D) FGA expression, (E) FGB expression, (F) FGG
expression, (G) PLAT expression and (H) PLAU expression. Data are presented as mean fold change ± SEM. Data were analysed by one-way ANOVA
followed by Tukey post hoc test. *P < 0.05, **P < 0.01.
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In agreement with previous work (Sindram-Trujillo et al., 2004;
Williams et al., 2009; Gomez-Lopez et al., 2013; Bartmann et al.,
2014), we found that the decidua, both at term and preterm, hosts a
variety of lymphocytes, including NK cells, T cells, B cells and iNKT
cells, of which T cells and NK cells made up the largest proportions of
the decidual CD45+ lymphocytes. There are conﬂicting reports on
labour- and gestation-associated changes in overall leucocyte density
in the decidua, with some studies reporting an increase in the CD45+
population at term compared to preterm (Gomez-Lopez et al., 2013;
Bartmann et al., 2014), whilst another study found no difference in the
decidual CD45+ population in women at term, either in labour or not
in labour, or in women in PTL (Hamilton et al., 2012). The results in
the current study were in agreement with Hamilton et al. (2012), with
no signiﬁcant difference in the number of CD45+ lymphocytes
between decidua recovered from our four patient groups. Similarly,
there is little consensus on changes to decidual T cell number, with
one study reporting elevated T cell number at term, compared to pre-
term (Gomez-Lopez et al., 2013), which contrasts another study
reporting a signiﬁcant increase in CD3+ T cells in PTL samples com-
pared to TL samples (Hamilton et al., 2012). Hamilton et al. (2012)
also report a signiﬁcant increase in CD56+ NK cells in decidua from
women in PTL compared to TL, however we found no signiﬁcant dif-
ference in decidual T cell or NK cell populations in our sample groups
(TNL, TL, PTNL and PTL).
The lack of agreement between the different studies highlights the dif-
ﬁculty in characterizing changes in decidual immune cell populations, as
in each study there is quite high inter-patient variability. Given the limited
number of studies that have investigated the decidual immune cell popu-
lations in relation to parturition, particularly in PTL, conﬁrmatory studies
with larger sample sizes would be helpful. Our preterm sample sizes
were particularly limited not only due to the difﬁculty in obtaining pre-
term samples but also because of the limited availability of decidual tis-
sue present on the preterm foetal membranes. Therefore, some
samples did not provide a large enough decidual leucocyte population
for ﬂow cytometry analysis. The differences in the results presented
here and in previously published studies (where labour-associated differ-
ences in immune cell populations were observed) may be explained by
methodological differences. Both our study and that by Gomez-Lopez
et al. (2013) used ﬂow cytometry analysis, which allowed us to quantify
and stain the whole panel of lymphocytes present in our decidual sam-
ples. In contrast, Hamilton et al. (2012) took an immunohistochemical
approach with manual counting of a ﬁxed number of ﬁelds of view.
Furthermore, our decidual samples were collected by carefully scraping
decidua parietalis from the chorion layer of the foetal membranes,
allowing us to speciﬁcally analyse the decidua parietalis lymphocyte
populations. However, in the other studies the chorio-decidua together
or decidua basalis was examined. Although both decidua basalis and
decidua parietalis are part of the decidual tissue, they are composed of
different cell types and it has previously been shown that there is differ-
ential distribution of NK cells and T cells at term between the two
decidual tissue sites (Sindram-Trujillo et al., 2003a, b). Therefore, it is
important to note that the observations in our study are speciﬁc to the
decidua parietalis and there may be alterations in lymphocyte cell num-
ber in the decidua basalis in association with term and PTL, which we
have not studied here. We believe that our study, in which we have
focussed on the decidua parietalis only and used the gold standard
method of ﬂow cytometry to count cells, is robust, and that our ﬁnding
that there is no difference in decidual cell lymphocyte cell density in
association with parturition (at least in the decidua parietalis) is likely to
be reproducible.
It should also be noted that we have only examined the proportion
of each lymphocyte population in this study and have not measured
the activation status of these lymphocytes. The ability of leucocytes,
present in gestational tissues at the time of parturition, to contribute
to the inﬂammatory response by producing pro-inﬂammatory cyto-
kines, chemokines and MMPs has been well described (Roh et al.,
2000; Young et al., 2002; Gomez-Lopez et al., 2013). Future studies
examining whether these decidual lymphocytes are activated and pro-
ducing pro-inﬂammatory mediators will give further information on
whether they provide a functional role in the labour process either at
term or preterm.
In recent years, decidual iNKT cells have become an immune cell
subpopulation of particular interest in the context of PTB (Rinaldi
et al., 2015). The presence of iNKT cells in both the pregnant human
and mouse decidua has been established (Ito et al., 2000; Tsuda et al.,
2001; Boyson et al., 2002; St Louis et al., 2016; Negishi et al., 2017).
Animal studies have suggested a key role for iNKT cells in driving PTL,
where iNKT cell activation has been shown to result in both early
pregnancy loss and PTB in the mouse (Ito et al., 2000; Boyson et al.,
2002; Li et al., 2015; St Louis et al., 2016). Furthermore, Jα18 knockout
mice, which lack iNKT cells, have been shown to have a reduced rate
of lipopolysaccharide (LPS)-induced early pregnancy loss and PTB
(Li et al., 2012; 2013). These studies provided compelling evidence
that iNKT cells likely play an important pathological role in PTL in
mice, and a recent study has reported that iNKT cell number is higher
in decidual samples collected from women in PTB without chorioam-
nionitis compared with PTB with chorioamnionitis (Negishi et al.,
2017). Prior to the data shown here, no other studies had investigated
whether the proportions of decidual iNKT cells are altered in human
labour both at term and preterm.
In this study, we identiﬁed a small population of CD3+ TCRVα24-
Jα18 + iNKT cells in the decidua samples collected from each of our
four patient groups, which accounted for around 0.1% of the decidual
CD3+ T cell population. Reports of third trimester decidual iNKT cell
numbers are limited, with only two other studies having recently pub-
lished these data (St Louis et al., 2016; Negishi et al., 2017), although
one study only examined ‘iNKT-like’ cells and the other study only
examined iNKT cells in women with late PTB (34–36 weeks). In con-
trast to our ﬁndings of no difference in decidual iNKT cell number
between our four patient groups, both studies report elevated num-
bers of ‘iNKT-like’ and iNKT cells in decidual samples from women
with non-infection-associated PTL. Due to differences in study design,
patient inclusion criteria and iNKT cell markers used, it is difﬁcult to
make direct comparisons across the three studies, however given our
use of antibodies against the speciﬁc iNKT cell marker in our study
(TCRVα24-Jα18) and our inclusion of our four patient groups (TNL,
TL, PTNL and PTL), we believe our data more accurately reﬂects the
true proportion of iNKT cells in third trimester decidua in both labour
and PTL. Future studies with larger sample sizes are required to fur-
ther investigate decidual iNKT cell numbers in PTL.
Interestingly, although we did not observe a difference in iNKT cell
number in PTL decidua, we found increased expression of the non-
classical MHC-protein, CD1d at both the mRNA and protein level in
decidual samples collected from patients in PTL. CD1d is involved in
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iNKT cell activation via lipid antigen presentation (Brennan et al.,
2013), and is expressed on professional-antigen presenting cells
(APCs), including macrophages, dendritic cells, B cells, activated T cells
(Exley et al., 2000; Brigl and Brenner, 2004) and intestinal epithelial
cells (Blumberg et al., 1991). Decidual CD1d expression has been
reported on both villous and extravillous trophoblast cells (Boyson
et al., 2002; Matsumoto et al., 2008) and its expression increases as
gestation progresses (Shao et al., 2005). To the best of our knowledge,
this is the ﬁrst study to examine CD1d expression in third trimester
decidual samples collected from TNL, TL, PTNL and PTL women, and
the ﬁrst study to report elevated decidual CD1d expression in associ-
ation with PTL.
The reason for the greater CD1d expression in our PTL samples
(compared to TNL and PTNL) is currently unclear, but it has been
previously shown that CD1d expression on APC can be induced by
inﬂammatory cytokines, such as IFN-γ and TNF or in the presence of
bacteria (Skold et al., 2005). Given that 50% of our PTL samples had
conﬁrmed chorioamnionitis (as might be expected), and that we
showed increased expression of a number of inﬂammatory mediators
in PTL decidua samples (according to our microarray results), it is pos-
sible that this mechanism explains the elevated CD1d observed in our
samples. Interestingly, this ﬁnding suggests that although we did not
see an increase in the proportion of decidual iNKT cells present in PTL
decidua samples, the increased CD1d expression may result in more
activated iNKT cells in PTL decidua, which could go on to stimulate
other immune cells and contribute to the pathological inﬂammatory
response associated with PTL. In support of this hypothesis, St Louis
et al. (2016) reported the presence of activated iNKT cells (CD3+
Vα24 Jα18TCR + CD69+ cells) in PTL and TL decidua samples
(St Louis et al., 2016), but no formal quantiﬁcation of these activated
cells was reported. Further work is required to conﬁrm this observa-
tion, but our results along with that of St Louis et al. (2016), suggest
that the relationship between decidual iNKT cells and CD1d in PTL
warrants further investigation.
To complement the analysis of decidual immune cell populations,
we also investigated the decidual transcriptome in our four patient
groups. Although several genome-wide microarray studies have been
carried out to improve our understanding of the gene expression
changes associated with the onset of labour, the decidua has been
largely neglected compared to other gestational tissues (Eidem et al.,
2015). To date, only two other transcriptomic studies have reported
examining the labour-associated gene expression changes in the
human decidua, with one studying focusing on term labour (Stephen
et al., 2015) and the other study focussing on PTL (Shankar et al.,
2010). Our microarray data presented here complements and extends
these studies, by examining the gene expression signature of the
decidua during both term and PTL.
Our ﬁndings are broadly in agreement with the study of Stephen
et al. (2015), demonstrating that term labour is associated with exten-
sive inﬂammatory activation, as has been established for other gesta-
tional tissues such as the myometrium, foetal membranes and cervix
(Bollapragada et al., 2009; Mittal et al., 2010; Weiner et al., 2010;
Sharp et al., 2016). KEGG pathway analysis revealed that several
inﬂammatory and immune pathways were enriched in TL samples,
including ‘TNF-signalling pathway’, ‘NOD-like receptor signalling path-
way’, ‘NF-kappa B signalling pathway’ and ‘Toll like receptor signalling
pathway’. Additionally, our qRT-PCR results validated the ﬁnding that
a number of important inﬂammatory genes were signiﬁcantly up-
regulated in TL samples compared with TNL decidua. Notably ele-
vated expression of genes with an established role in parturition (such
as IL-6 and PTGS2) is in line with expectations (Keelan et al., 2003;
Osman et al., 2006; Bollapragada et al., 2009). We also describe, for
the ﬁrst time, that the decidua from women in TL has elevated expres-
sion of a number of genes that are involved in negatively regulating
inﬂammation, namely IER3, TNFAIP3 and ATF3. This may suggest that
whilst the decidua contributes to the pro-inﬂammatory signalling asso-
ciated with the onset of parturition, it may also have an important role
in maintaining inﬂammatory homoeostasis during physiological term
labour. In support of this hypothesis, a recent study investigating
inﬂammatory gene networks in term human decidual stromal cells sti-
mulated with IL-1β in vitro identiﬁed the up-regulation of several
microRNAs that regulate pro-inﬂammatory gene expression (Ibrahim
et al., 2016).
To determine whether there was a speciﬁc decidual gene signature
associated with PTL we also compared gene expression in PTL sam-
ples with both TL and PTNL samples. Our network graph analysis
demonstrated that the PTL samples appeared to have the most similar
gene expression, with 75% of these samples clustering together. This
analysis, followed by our KEGG pathway enrichment analysis and qRT-
PCR validations have led us to identify several genes of interest that
are signiﬁcantly elevated in PTL samples.
KEGG pathway analysis identiﬁed that one of the top enriched path-
ways in our PTL samples was ‘complement and coagulation cascades’.
Such a link has been reported in other studies (Bogic et al., 1999;
Elovitz et al., 2001; Norwitz et al., 2007; Velez et al., 2008; Shankar
et al., 2010; Phillippe et al., 2011), although with PCR we were unable
to validate up-regulation of complement and coagulation associated
genes: FGA, FGB, FGG and PLAT, which we showed in the microarray.
We did validate elevated expression of PLAU, which encodes for uro-
kinase plasminogen activator (uPA). uPA is a serine protease which is
involved in converting inactive plasminogen to plasmin and can regu-
late ECM degradation by activating MMPs (Vassalli et al., 1991; Baricos
et al., 1995; Zhao et al., 2008). In gestational tissues, high uPA expres-
sion has been reported in the decidual cells adjacent to the area of foe-
tal membrane rupture in humans and rhesus monkeys (Liu et al.,
1998). To the best of our knowledge, we believe this is the ﬁrst study
to report elevated expression of PLAU in decidua collected from
women in PTL. We know that labour is associated with signiﬁcant
ECM remodelling and MMP activity within the decidua (Ulug et al.,
2001; Li et al., 2004); therefore given the link between uPA, plasmin
and MMP activity, it is possible that this elevated PLAU expression in
PTL may promote premature ECM degradation and foetal membrane
rupture, resulting in the onset of PTL.
Another important pathway which was highlighted by our KEGG
analysis to be signiﬁcantly up-regulated in PTL was ‘cytokine–cytokine
receptor interaction’, suggesting that inﬂammatory signalling also plays
a role in the pathogenesis of PTL, as observed in TL. Indeed, we valid-
ated the mRNA expression of several genes that are linked to inﬂam-
mation by qRT-PCR which were signiﬁcantly elevated only in PTL
decidua samples, CXCL8, MARCO, and LILRA3. Of these three genes,
only CXCL8 has been previously linked to parturition (Romero et al.,
1991; Kelly et al., 1992; Osmers et al., 1995; Denison et al., 1998;
Tornblom et al., 2005; Gomez-Lopez et al., 2009; Hamilton et al.,
2013; Stephen et al., 2015). The other two inﬂammation-related
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genes, MARCO and LILRA3, have not previously been linked to PTL,
and could be interesting novel targets for therapeutic investigation.
MARCO (macrophage receptor with collagenous structure) is a class
A scavenger receptor encoded by the MARCO gene, which is constitu-
tively expressed by subsets of macrophages and has been shown to be
up-regulated in the presence of infection or in inﬂammatory conditions
in vivo (van der Laan et al., 1999; Seta et al., 2001; Milne et al., 2005).
MARCO has been detected in human and mouse decidual macro-
phages, where it has been reported to have an important role in the
clearance of intrauterine infection with Clostridium sordellii (Thelen
et al., 2010). LILRA3 (leucocyte immunoglobulin-like receptor-3),
which encodes the LILRA3 protein, belongs to a family of LILR recep-
tors, which have diverse activating and inhibitory actions on the
immune response by altering the signalling of other immune receptors
(Brown et al., 2004). LILRA3 is secreted by immune cells, such as
monocytes, mast cells, B cells and some subsets of T cells (Hirayasu
and Arase, 2015). Only one other study has reported LILRA3 expres-
sion in relation to parturition, where LILRA3 expression was shown to
be signiﬁcantly down-regulated in the myometrium from women with
dystocia, compared to women with normal uterine function (Brennan
et al., 2011); suggesting that LILRA3 may be involved in regulating the
inﬂammatory and immune response which drives physiological labour
at term. Hence, MARCO and LILRA3, which we link to PTL for the ﬁrst
time, have the potential to be important mediators in the pathological
process of PTL and warrant further investigation.
Taken together, our decidual transcriptome studies demonstrate
that there are widespread gene expression changes with labour onset,
both at term and preterm, but importantly there are differences in the
gene expression changes in TL and PTL. This ﬁnding agrees with the
theory that PTL cannot simply be considered as labour that occurs too
soon (Romero et al., 2014). Although in both parturition processes we
observed up-regulation of genes related to inﬂammatory processes,
we were able to identify speciﬁc genes that were elevated only in TL
or PTL. Therefore, using whole genome analysis, as we have done in
this study, will help us to identify genes that are particularly involved in
the pathological onset of PTL, which may help in the identiﬁcation of
novel therapeutic targets for PTB.
We believe the results presented in this study provide an important
step forward in understanding the function of the decidua in both term
and PTL as we have analysed the lymphocyte populations present
within the decidua and carried out the ﬁrst transcriptomic analysis
using puriﬁed decidua tissue. However, we do recognize there are
some limitations to our study. Our decidual immune cell analysis
focused on the lymphocyte populations, therefore we are unable to
comment on the contribution of decidual neutrophils or macrophages
to TL or PTL in our samples, but these cell populations have been
extensively examined elsewhere (Osman et al., 2003; Hamilton et al.,
2012; Kim et al., 2012; Shynlova et al., 2013a, b). Another limitation to
our study is that due to the difﬁculty in obtaining decidual samples, par-
ticularly from our preterm groups, it was necessary to perform the
qRT-PCR validations on the same sample set. Additionally, our pre-
term samples (both PTL and PTNL) inevitably came from women with
a range of underlying complications (e.g. chorioamnionitis, pre-
eclampsia and IUGR), which may explain the high variability observed
in these patient groups, because it is simply not possible to collect pre-
term samples from women with no underlying pathologies. This is a
known limitation of studying PTL in women. Future studies, with very
large sample sizes which can subgroup the preterm patients into differ-
ent underlying pathologies may be more useful in identifying speciﬁc
transcriptomic differences underlying the different aetiologies of PTL.
In summary, the data presented here demonstrate that the onset of
parturition both at term and preterm is associated with widespread
gene expression changes in the decidua, but not alterations in the
number of lymphocytes present at the maternal–foetal interface (at
least not in the sub-populations examined here). As well as reporting
the elevated expression of pro-inﬂammatory genes, with known roles
in labour, importantly we report, for the ﬁrst time, the expression of
genes involved in the regulation of the inﬂammatory response.
Exploiting endogenous factors capable of regulating inﬂammation
within gestational tissues may be an effective novel therapeutic target.
Improving our understanding of the molecular mechanisms regulating
the onset of labour both at term and preterm is critical to the develop-
ment of new therapies for the treatment of PTB, which are urgently
required. Increasing evidence suggests the decidua likely plays on
important early role in the events triggering the onset of parturition,
therefore, it is possible that targeting molecular changes occurring in
the decidua may have more success than current therapies.
Supplementary data
Supplementary data are available at Molecular Human Reproduction
online.
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